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INTRODUCTION
After the discovery of ABO antigens on red blood
cells in 1900 from serological differences in human
blood (1), the ABO blood group was classified into
four antigens (A, B, O, and AB) and six genotypes
in 1924 (2-4). These antigens are oligosaccharide
antigens, and are widely distributed on the mem-
branes of red blood and tissue cells as well as in
saliva and other body fluids. Recently, the nucleotide
sequences of genes of the ABO blood group in chro-
mosome 9q34, seven single base substitutions char-
acterizing A compared with B and a single base de-
letion characterizing A compared with O, were de-
termined (5-8). This has made it possible to analyze
the ABO genotype using molecular biological tech-
niques (9-16).
The A and B antigenic structures of the ABO
blood group are defined as the carbohydrate de-
terminants synthesized from the H precursor struc-
ture by the glycosyltransferase products of A and
B genes, respectively (17). Therefore, the detec-
tion of ABO blood group antigens and genetic analy-
sis of the ABO blood group are important in both
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transfusion and organ transplantation. Furthermore,
the ABO blood group system is one of the most im-
portant markers of personal identification in foren-
sics.
The classical method of detecting ABO antigens
is the hemagglutination assay. This technique is sim-
ple, inexpensive, and is sufficient for routine ABO
blood group typing in transfusion. However, hemag-
glutination, which is a qualitative assay, has certain
limitations : it is difficult to quantify ABO antigens
on red blood cells, and it does not precisely indi-
cate the ABO blood type in normal or subgroups.
In this study, we described the development and
use of quantitative analysis of A, B, and H antigens
by flow cytometric analysis and an ABO genotyp-
ing method based on PCR amplification of specific
alleles (PASA) within DNA, especially from blood
and saliva.
MATERIALS AND METHODS
Subjects
Peripheral blood samples (n=28, A type : 5, B
type : 5, O type : 5, AB type : 5, cisA1B3 type : 2,
cisA2B3 type : 5, A2B type : 1) were collected from
healthy volunteers who had previously been typed
serologically and genotyped.
Preparation of glutaraldehyde-fixed spherical red
blood cells
Blood anti-coagulated with EDTA-2K was cen-
trifuged at 1,000g for 10 min to separate the red
blood cells from plasma, and washed three times
in saline (1,000g/2 min). Nine μL of packed red
blood cells was added to 291 μL of saline, and then
1.5 ml of 0.11% glutaraldehyde fixing solution buffer
containing 0.035 mM sodium dodecyl sulfate, 4.03
mM EDTA2Na, 3.36 mM EDTA4Na, and 109.3
mM NaCl (ADVIA 120 RBC/PLT reagent, Bayer
Medical) for spheroidization and fixation was added,
followed by incubation for 15 min at room tempera-
ture. It was then washed two times (1,000g/2
min) with saline, and we finally prepared a 1.5% red
blood cell saline suspension.
Flow cytometric analysis of A, B, and H antigens
Measurement of A and B antigens : Anti-human A
and B mouse antibodies (Ortho-Clinical Diagnos-
tics) were used as the first antibody and anti-Mouse
IgM, H&L Chain Specific Fluorescein (FITC) Conju-
gate (Merck) as the second antibody. The negative
control for the first antibody was a 1 : 30 dilution of
Mouse IgM antibody (Dako). Fifty μl of a 1.5% red
blood cell saline suspension was first incubated with
50 μl of a 1 : 64 dilution of the first antibody for 60
min at room temperature and, subsequently, washed
two times (3,400 rpm/2 min) with saline, and then
incubated again with 50 μl of a 1 : 100 dilution of
the second antibody for 30 min at 4. It was then
washed two times (3,400 rpm/2 min) and resus-
pended in saline, and analyzed employing FACS
CaliburTM (Becton Dickinson).
Measurement of H antigen : Fifty μl of a 1.5% red
blood cell saline suspension was first incubated
with 50 μl of a 1 : 100 dilution of lectin from Ulex
europaeus agglutinin-1 Fluorescein Conjugate (UEA-
1, detecting H antigen) (Sigma) for 60 min at 4.
As a negative control, 50 μl of a 1.5% red blood cell
saline suspension was incubated with 50 μl of a
mixture of 1 : 100 dilutions of UEA-1 and 100 mM
of L-Fucose for 60 min at 4. These samples were
washed two times (3,400 rpm/2 min), and resus-
pended in saline, and immunophenotypes were ana-
lyzed employing FACS CaliburTM (Becton Dickin-
son).
DNA extraction from saliva using magnetic bead
method
Forty μl of a saliva sample and 100 μl of a solution
containing 7 μl of resin and 93 μl of Lysis Buffer
from the DNA IQTM Kit (promega) were added to a
1.5 microcentrifuge tube and vortexed for 3 sec at
high speed, and then incubated at room tempera-
ture for 5 min. The mixture was vortexed again for
3 sec once every min during the 5 min incubation,
and placed the tube in the magnetic stand. All of
the mixture was carefully removed and discarded
without disturbing the resin pellet on the side of
the tube, and then 100 μl of Lysis Buffer was added,
the tube was removed from the magnetic stand,
vortexed for 2 sec, and then placed again on the
magnetic stand. All Lysis Buffer was carefully dis-
carded without disturbing the resin. The resin was
washed with 100 μl of 1Wash Buffer, vortexed
for 2 sec, and the tube was placed again on the mag-
netic stand. Wash Buffer was carefully discarded
without disturbing the resin. The same washing pro-
cedure was repeated for a total of three washes.
After the last wash, the tube was allowed to air-dry
on the magmatic stand with the lid open for 5 min
at room temperature, and 50 - 100 μl of Elution
Buffer was then added and the lid was closed. The
mixture was vortexed for 2 sec at high speed, and
K. Aki, et al. Rapid and reliable ABO blood group analysis144
incubated at 65for 5 min. The tube was removed
from the heat, vortexed for 2 sec at high speed, and
immediately placed on the magnetic stand. Finally,
the DNA-containing solution was carefully trans-
ferred to another tube, and stored at 4or at -20.
ABO genotyping by polymerase chain reaction am-
plification of the specific allele (PASA)
The type of PASA reaction distinguishes the dif-
ferent ABO genotypes on the basis of the molecu-
lar size of allele-specific amplification products that
contain 261, 526, 796, and 803 nucleotides (the sites
of amino acid substitutions) in ABO allelic cDNA.
The details of the procedure and validation of the
PASA method for ABO genotyping were reported
elsewhere (12-14). Briefly, for the six major ABO
genotypes and ABO subtypes : A/O , A/A , B/O , B/B ,
O/O , A/B , and A2B3/O , three specific bands (379,
104, and 52 bp), two specific bands (379 and 52 bp),
four specific bands (379, 224, 104, and 52 bp), two
specific bands (224 and 52 bp), two specific bands
(379 and 104 bp), three specific bands (379, 224,
and 52 bp) and four specific bands (379, 104, 52,
and 55 bp) were amplified, respectively. In this pre-
sent study, we modified specific primer designs
and PCR conditions from the conventional PASA
method to improve the specificity and stability of
allele-specific amplification with saliva samples. The
scheme of the amplification method and analysis
of specific ABO alleles using the PASA method are
shown in Figure 1, and a summary of the primer
sequences and all possible specific bands of ABO
genotype patterns obtained with the PASA method
are given in Tables 1 and 2, respectively (12-14).
Figure 1 Scheme of amplification and analysis of specific ABO alleles using the PASA method.
The 3’ endbase of primers 2, 3 and 4, 6, 7, and 9, and 10 corresponded to the nucleotide sequences of O, A and B, B, A, and O, and
cisAB alleles, respectively. Primers 1, 5, and 8 corresponded to the nucleotide sequence of the ABO allele. Allele -specific DNA frag-
ments of the O allele (104 bp), A and B alleles (52 bp), B allele (224 bp), A and O alleles (379 bp) and, cisAB allele (55 bp) were
amplified by PCR with five primer pairs (primers 1 and 2, primers 3 and 4, primers 5 and 6, primers 7 and 8, and primers 9 and 10,
respectively. Three (104, 224, and 379 bp) of five fragments were co-amplified in a single PCR 1 (multiplex-PCR). Primers 2, 6, and
10 were inserted at an artificial mismatched nucleotide at the second nucleotide from the 3’ end of primers.
Table 1 Patterns of PASA method for all possible ABO genotypes
bp (Allele -specific band) A/O A/A B/O B/B O/O A/B cisABA2B3/O A2B3/A1 A2B3/B
(a) 379 (A,O-specific) + + + - + + + + +
(b) 224 (B-specific) - - + + - + - - +
(c) 104 (O-specific) + - + - + - + - -
(d) 52 (A,B-specific) + + + + - + + + +
(e) 55 (cisAB-specific) - - - - - - + + +
+, Presence of the expected specific ABO gene-type fragment. -, Absence of the expected specific ABO gene-type fragment. (a),
Specific band A and O alleles using primers (7 and 8). (b), Specific band B allele using primers (5 and 6). (c), Specific band of O
allele using primers (1 and 2). (d), Specific band of A and B alleles using primers (3 and 4). (e), Specific band of cisAB allele using
primers (9 and 10).
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PCR conditions
PCR 1, 2, and 3 amplifications using the two sets
of primers were carried out in a final volume of 25
μl, containing 10-20 ng of DNA, 50 pmol of each
primer, 1 μl of 360 GC enhancer, and 12.5 μl of
AmpliTaq Gold 360 Master Mix (Applied Biosys-
tems). PCR 1, 2, and 3 amplification conditions were
an initial denaturation step at 95for 10 minutes,
followed by 33 cycles of denaturation at 95for 30
sec, annealing at 66for 30 sec, and extension at
72for 30 sec, and the last cycle extension was
performed for 7 min at 72, followed by a quick
chill to 4. The PCR product was mixed with gel of
loading buffer and applied to 3% agrose gel (Wako,
Osaka, Japan) that contained 0.5 μg/ml of ethid-
ium bromide. Electrophoresis was visualized with
Printgraph (ATTO, Tokyo, Japan).
RESULTS
Expression of A, B, and H antigens on red blood
cells
The expression of A, B, and H antigens on red
blood cells of various phenotypes was quantitatively
compared by fluorescence labeling. Figure 2 sum-
marizes the distribution patterns with respect to
Table 2 The sequences of primers used in this study
Name Sequence (5’3’) Length (bp)
(1) fy-57 GAATTCATGTGGGTGGCACCCTGCCA 26
(2) 261-O2G AGACAATGGGAGCCAGCCAAGGGGGA 26
(3) AB-261N AGACAATGGGAGCCAGCCAAGGGGTC 26
(4) 261-AB GAATTCAGGAAGGATGTCCTCGTGGTG 27
(5) fy-43 GGATCCAGGGGTGCACGGCCGGCGGC 26
(6) 526-B2 CTGCCAGCGCTTGTAGGCGTC 21
(7) 526-A CAGCTGTCAGTGCTGGAGGTGC 22
(8) Fy-2 CCGTTGGCCTGGTCGACCATCATGGCCTG 29
(9) 796-A AAGGACGAGGGCGATTTCTACTACC 25
(10) 803-B2 TCTTGCACCGACCCCCCGAAGAATG 25
The 3’ endbase of primers (2), (3) and (4), (6) , (7), and (9), and (10) corresponded to the nucleotide sequences of O, A and B, B, A,
and O, and cisAB alleles, respectively. Primers (1), (5), and (8) corresponded to the nucleotide sequence of the ABO allele. Primers
(2), (6), and (10) were inserted at an artificial mismatched nucleotide at the second nucleotide from the 3’ end of primers.
Figure 2 The expression patterns of A, B, and H antigens of red blood cells of four principal ABO blood types and three subtypes
of type AB by flow cytometry.
(a), type A ; (b), type B ; (c), type O ; (d), type AB, (e), type A2B, (f), type cisA1B3 ; (g), type A2B3. The horizontal axis shows fluores-
cence intensity and the vertical axis shows cell counts for each antigen. Solid red and solid blue line histograms show A and B anti-
gens on red blood cells, respectively, and the solid black histogram shows H antigens on red blood cells.
K. Aki, et al. Rapid and reliable ABO blood group analysis146
the intensity of the fluorescence of red blood cells
of various representative phenotypes labeled for A,
B, and H antigens.
When red blood cells with the various phenotypes
were labeled with anti-A and/or anti-B antibodies
and UEA-1 lectin, A, B, O, AB, A2B, cisA1B3, and
cisA2B3 could be clearly distinguished. Variations
in fluorescence patterns could be used to compare
differences between expressions of A and/or B an-
tigens, and H antigens on red blood cells with vari-
ous phenotypes. Figure 3 shows the percentage of
A, B, and H antigens on red blood cells of types A,
B, O, AB, A2B, cisA1B3, and cisA2B3. For type A, the
positive rate of A antigen was 98.00.9%, and was
clearly higher than type A2B (49.1%) and cisA2B3
(72.96.5%), and slightly higher than type AB
(94.01.6%) and cisA1B3 (94.50.8%). For type B,
the positive rate of B antigen was 97.51.0%, and
was clearly higher than type cisA1B3 (10.80.9%)
and cisA2B3 (6.94.0%), and higher than type AB
(84.94.2%), and slightly lower than A2B (98.8%).
For type O, the positive rate of H antigen was 76.6
13.5%, and was reduced in the order of type B
(27.87.0%), A (18.84.1%), and AB (9.74.0%).
On the other hand, three subtypes of type AB were
clearly higher than type AB, and the positive rate
of H antigen was high in the order of type A2B
(40.5%), cisA1B3 (47.32.1%), and cisA2B3 (62.7
7.9%). These data show a reciprocal relationship be-
tween the expression of A and/or B antigens, and H
antigens on red blood cells in subtypes of type AB.
ABO genotyping by PASA
In this study, the type of PASA reaction could be
used to distinguish the different ABO genotypes
of genomic DNA extracted from the saliva and/or
blood samples donated from volunteers, and 6 mem-
bers belonging to one cisA2B3 pedigree on the basis
of the molecular size of allele-specific amplification
products that contain 261, 526, 796, and 803 nucleo-
tides (the sites of amino substitution) in ABO alle-
lic cDNA.
Figure 3 Quantitative comparison of A and/or B and H antigens of red blood cells of A, B, O, AB, A2B, cisA1B3, and cisA2B3 ana-
lyzed by flow cytometry.
(a), The positive rate of A antigen (meanSD) ; (b), The positive rate of B antigen (meanSD) ; (c), The positive rate of H antigen
(meanSD), A, B, O, and AB (n=5), A2B (n=1), cisA1B3 (n=2), and cisA2B3 (n=5).
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As shown in Figure 4, all genes of the five major
ABO genotypes, A/O , A/A , B/O , O/O , and A/B , ex-
cept for B/B , were amplified using DNA extracted
from saliva ; three specific bands (379, 104, and 52
bp) for A/O , two specific bands (379 and 52 bp) for
A/A , four specific bands (379, 224, 104, and 52 bp)
for B/O , two specific bands (379 and 104 bp) for O/
O , and three specific bands (379, 224, and 52 bp)
for A/B . Under this PASA condition, only the spe-
cific bands were amplified in each genotype (band
of 560 bp in PCR 1 is a common band in all blood
types). In addition, Figure 5 shows a comparison
of analysis with DNA extracted from saliva and
blood obtained from the same person. The analysis
of DNA extracted from blood employed a previously
established method (12-14). The results of analysis
using saliva were the same as those using blood,
and could be used to distinguish the ABO geno-
types.
Figure 6 shows patterns of amplification of typi-
cal types of A/O , O/O , and cisA2B3/O and Figure 7
summarizes the phenotype and genotype of the
Figure 4 Electrophoretic patterns of PCR products in the 5 ma-
jor ABO genotypes (A/O , A/A , B/O , O/O , and A/B ).
Genomic DNA extracted from saliva was amplified employing the
PASA method using 4 primer sets [?1 , PCR 1(primers 1 and 2,
primers 5 and 6, and primers 7 and 8), ?2 , PCR 2 (primers 3
and 4)]. M, 50 bp DNA size marker, Band of 560 bp in PCR 1 is
a common band in all types.
Figure 5 Electrophoretic patterns of PCR products in AB and
O genotypes.
DNA extracted from saliva (a) and blood (b) obtained from same
person was amplified with the PASA method using 4 primer sets
[?1 , PCR 1(primers 1 and 2, primers 5 and 6, and primers 7 and
8),?2 , PCR 2 (primers 3 and 4)]. M, 50 bp DNA size marker,
Band of 560 bp in PCR 1 is a common band in all types.
Figure 7 A pedigree chart of cisA2B3 family. Black : subjects
with type cisA2B3, arrow : propositus.
Figure 6 Electrophoretic patterns of PCR products in typical
type A/O , O/O , and cisA2B3/O .
DNA extracted from saliva was amplified employing the PASA
method using 5 primer sets [?1 , PCR 1(primers 1 and 2, prim-
ers 5 and 6, and primers 7 and 8),?2 , PCR 2 (primers 3 and 4),
?3 , PCR 3 (primers 9 and 10]. M, 50 bp DNA size marker, Band
of 560 bp in PCR 1 is a common band in all types.
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cisA2B3 family pedigree. All genes of the six per-
sons’ ABO genotypes in the cisA2B3 pedigree were
amplified using DNA extracted from saliva : 379,
104, 52, and 55 bp for the grandfather, 379 and 104
bp for the grandmother, 379, 104, 52, and 55 bp for
the father, 379 and 104 bp for the mother, and 379,
104, 52, and 55 bp for the two children (data not
shown except for the propositus and mother). There-
fore, the grandfather, father, and two children were
determined to be type cisA2B3, and the grandmother
and mother were determined to be type O.
DISCUSSION
The ABO blood group system is the most impor-
tant in both transfusion and organ transplantation,
especially the evaluation of the adaptability of a
donor’s blood cells with bone marrow transplanta-
tion and hemocyte survival confirmation. Further-
more, the ABO blood group system is one of the
most important markers of personal identification
in forensics.
Currently, the ABO blood group antigens are de-
termined by tube or column hemagglutination meth-
ods using anti-A or anti-B antibodies. These tech-
niques are simple, and are sufficient for routine
ABO blood group typing in transfusion, but such
hemagglutinations are merely observations of a
secondary reaction in antibody sensitization on the
red blood cell membranes (18), and often show un-
reliable results in determining the blood type anti-
gens, and it is difficult to quantify ABO antigens on
red blood cells. Thus, we attempted to develop a
quantitative analysis method for A, B, and H anti-
gens on red cells by employing flow cytometric
analysis. This analysis can observe the first phase
of the binding state of antibodies (19), and can com-
pare the number of antigens on the red blood cells
by measuring the fluorescence intensity of binding
antibody labeled with a fluorescent dye such as fluo-
rescein isothiocyanate (20). Although this flow cy-
tometric analysis is simple method, it is important
to make examination in an optimal concentration of
the first and second antibodies. Therefore, the op-
timal antibody concentration must be determined
experimentally in each assay for stable results. In
this study, we demonstrated that the positive rate
of H antigen decreases in the order of type O, B,
A, and AB. This result is consistent with that of
Bianco et al. (21).
In addition, we were able to capture differences
with a very small amount of A and B antigens on
red blood cells, whereby the positive rate of A or B
antigens of type AB, which has both A and B anti-
gens, was lower than type A or B, which has either
an A or B antigen. On the other hand, three sub-
types of type AB were observed with a decrease of
A and/or B antigens and an increase of H antigen.
The amount of A antigen in cisA2B3 and A2B was
less than in types A and AB, and the amount of B
antigen in cisA2B3 and cisA1B3 was less than in types
B and AB. In contrast, the amount of H antigen
was higher in all three subtypes. These results are
consistent with those of Heier et al. (22) and Yazer
et al. (23). Therefore, these subtypes of type AB
are distinguished by decreased amounts of A and
B antigens and an increased amount of H antigen
on red blood cells. Detecting these subtypes is im-
portant, especially in blood transfusion and resolv-
ing paternity using the ABO blood group system.
In recent years, the sequences of ABO blood
group genes in chromosome 9q34 have been deter-
mined, and it has become possible to detect ABO
genotyping using molecular biology techniques (9-
16). We previously reported that the PASA method
is useful for detecting the ABO genotype with DNA
extracted from the blood. However, blood sam-
pling is painful and, in same cases, blood can not be
drawn. Then, we attempted to establish an analysis
method using DNA extracted from saliva, which can
be collected non invasively. The collection of saliva
is very easy, but the amount of DNA extracted from
saliva is trace, and it was difficult to analyze ABO
genotyping by employing a previously established
PASA method. Therefore, it was necessary to im-
prove the DNA extraction and PASA methods. We
succeeded in extracting DNA of a sufficient quality
and quantity from saliva using the magnetic beads
method with the DNA IQTM Kit. On the other hand,
the PASA method was modified by altering the
PCR conditions and primer design. Originally, the
PASA method was developed for allelic analysis of
mutation. Therefore, the design of the primer is
very important, but it is not easy to design (24-25).
This method is based on the fact that PCR amplifica-
tion occurs only when the 3’ endbase of the primer
is matched to nucleotide No.261, 526, 796, or 803
of the ABO allelic cDNA, and three of five regions
of allelic DNA were co-amplified in a single PCR
(multiplex-PCR) in this study. Then, to improve the
specificity of allele-specific amplification, we de-
signed allele-specific primers in which a single ar-
tificial mismatched nucleotide was inserted at the
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second nucleotide from the 3’ end of primers (26),
and determined PCR conditions for multiplex-PCR.
As a result, non-specific bands was suppressed, and
it was possible to amplify only the specific band for
the genotype of each blood type, and amplified band
patterns were consistent with the analysis results
using DNA extracted from the blood.
In particular, this PASA method is useful for ana-
lyzing the type cisAB (i.e., cisA1B3, cisA2B3, and
cisA2B) family. Types cisA1B3, cisA2B3, and cisA2B
are very rare phenotypes, and have genotypes of
A2B3/A1, A2B3/O , and A2B3/B , respectively, and the
A2B3 gene is a special gene in which A and B genes
are located on the same chromosome. Types A2B3
and A1B3 are easily distinguished from the normal
type AB due to the presence of anti-B and anti-A
antibodies, but it is difficult to discriminate between
cisAB (A2B3/A1, A2B3/O, or A2B3/B ) and transAB (A1/
B3, A2/B, or A2/B ) by serological tests alone. Ulti-
mately, a pedigree study is required to determine
type cisAB. On the other hand, the PASA method
can determine type cisA2B3 quickly and easily with
DNA only extracted from saliva.
In conclusion, we developed two analysis meth-
ods based on flow cytometric and PASA analyses
for ABO phenotyping and ABO genotyping. Flow
cytometric analysis can quantify A, B, and H anti-
gens on red blood cells, and the PASA method al-
lows the simple and rapid detection of multiple sin-
gle nucleotide polymorphism (SNP) sites on the
ABO gene. These methods are simple and useful for
judging the ABO blood group system and genotyp-
ing, and are used widely throughout research and
clinical laboratories and forensic fields.
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